Clever Culture Systems announced that Novo Nordisk has ordered two additional APAS Independence instruments bringing its installed base to three.

Clever Culture Systems (CCS) is an Australian Biotechnology Company and leader in microbiology technology driven by artificial intelligence. The Company is publicly listed on the Australian Securities Exchange (ASX: CC5). Using artificial intelligence (AI) to deliver automation in microbiology, the company has developed a patent protected machine learning and intelligent imaging platform technology to deliver the only FDA cleared instrument utilising AI technology in microbiology. Our technologies are designed by microbiologists for microbiologists to ensure our products not only meet the needs of the laboratory but also seamlessly integrate within our customer’s workflow. Our team are highly experienced in biotechnology, laboratory automation, diagnostics and microbiology. THE CLEVER WAY TO AUTOMATE PLATE READING The market-leading, innovative technology streamlines busy laboratory workflows, offering a modular approach. The APAS Independence is a stand-alone automated culture plate reading instrument that accurately and efficiently screens and sorts significant and insignificant growth plates at a rate of 200 plates per hour. The modular system ensures you only pay for what you need. Choose from urine, infection control (antibiotic resistance), respiratory and MRSA modules. The innovative, FDA cleared culture plate classification system identifies negative plates, allowing microbiologists to focus on the positive and significant growth plates that require their time and expertise, accelerating patient diagnosis.

Founded 2013